392 related items for PubMed ID: 12027070
1. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
Hawksworth RJ, Sykes AP, Faris M, Mant T, Lee TH.
Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
[Abstract] [Full Text] [Related]
4. Safety of long-term treatment with HFA albuterol.
Ramsdell JW, Klinger NM, Ekholm BP, Colice GL.
Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
[Abstract] [Full Text] [Related]
5. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
Ramsdell JW, Colice GL, Ekholm BP, Klinger NM.
Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
[Abstract] [Full Text] [Related]
6. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E, Ekholm BP, Klinger NM, Colice GL.
J Asthma; 1999 Dec; 36(1):107-14. PubMed ID: 10077140
[Abstract] [Full Text] [Related]
7. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N, Williams M, Rimmer M, Kahl L, Jenkins M, SMO30006 and SMO30007 International Study Teams.
Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
[Abstract] [Full Text] [Related]
8. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[Abstract] [Full Text] [Related]
9. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Bleecker ER, Tinkelman DG, Ramsdell J, Ekholm BP, Klinger NM, Colice GL, Slade HB.
Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
[Abstract] [Full Text] [Related]
10. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J.
Eur J Clin Pharmacol; 1995 Feb; 48(6):473-7. PubMed ID: 8582466
[Abstract] [Full Text] [Related]
11. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
Lumry W, Noveck R, Weinstein S, Barnhart F, Vandermeer A, Murray A, Reisner C.
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
[Abstract] [Full Text] [Related]
12. Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group.
Salat D, Popov D, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S22-8. PubMed ID: 10919682
[Abstract] [Full Text] [Related]
13. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G.
Respiration; 2005 Jun; 72 Suppl 1():6-12. PubMed ID: 15915007
[Abstract] [Full Text] [Related]
14. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM, Langley SJ, Singh SD, Holden J, Monici Preti AP, Acerbi D, Poli G, Woodcock A.
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[Abstract] [Full Text] [Related]
15. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Jacobson K, Chervinsky P, Noonan M, Kane RE, Banerji D, Uryniak T.
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
[Abstract] [Full Text] [Related]
16. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
17. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Tripp K, McVicar WK, Nair P, Corren J, Pleskow WW, Goodwin E, Baumgartner RA, Hanrahan JP.
J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
[Abstract] [Full Text] [Related]
18. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
Shapiro GS, Klinger NM, Ekholm BP, Colice GL.
J Asthma; 2000 Dec; 37(8):667-75. PubMed ID: 11192231
[Abstract] [Full Text] [Related]
19. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A, Bhargava S, Singh V, Talwar D, Whig J, Rebello J, Purandare S, Gogtay J.
Int J Chron Obstruct Pulmon Dis; 2016 Dec; 11():1469-76. PubMed ID: 27418820
[Abstract] [Full Text] [Related]
20. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Boccuzzi SJ, Wogen J, Roehm JB.
Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
